Subscriber Authentication Point
lvrea
Home All issues Volume 25 / No 5 (Septembre 2016) Méd. Intensive Réa, 25 5 (2016) 537-541 References
Free Access
Issue
Méd. Intensive Réa
Volume 25, Number 5, Septembre 2016
Médecine d'urgence-Neuroréanimation
Page(s) 537 - 541
Section Mise Au Point / Update
DOI https://doi.org/10.1007/s13546-015-1163-2
Published online 17 March 2016
  • Sandroni C, Cariou A, Cavallaro F, et al (2014) Prognostication in comatose survivors of cardiac arrest: an advisory statement from the European Resuscitation Council and the European Society of Intensive Care Medicine. Intensive Care Med 40:1816–31 [CrossRef] [PubMed] [Google Scholar]
  • Fahn S (2002) Overview, history, and classification of myoclonus. Adv Neurol 89:13–7 [PubMed] [Google Scholar]
  • Hallett M (2000) Physiology of human posthypoxic myoclonus. Mov Disord 15(Suppl 1):8–13 [CrossRef] [PubMed] [Google Scholar]
  • Lance JW, Adams RD (1963) The syndrome of intention or action myoclonus as a sequel to hypoxic encephalopathy. Brain 86:111–36 [CrossRef] [PubMed] [Google Scholar]
  • Marsden CD, Obeso JA, Rothwell JC (1983) Clinical neurophysiology of muscle jerks: myoclonus, chorea, and tics. Adv Neurol 39:865–81 [PubMed] [Google Scholar]
  • Shibasaki H (2000) Electrophysiological studies of myoclonus. Muscle Nerve 23:321–35 [CrossRef] [PubMed] [Google Scholar]
  • Dijk JM, Tijssen MA (2010) Management of patients with myoclonus: available therapies and the need for an evidence-based approach. Lancet Neurol 9:1028–36 [CrossRef] [PubMed] [Google Scholar]
  • Ugawa Y, Hanajima R, Okabe S, Yuasa K (2002) Neurophysiology of cortical positive myoclonus. Adv Neurol 89:89–97 [PubMed] [Google Scholar]
  • Wijdicks EF, Hijdra A, Young GB, et al (2006) Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 67:203–10 [CrossRef] [PubMed] [Google Scholar]
  • Lhermitte F, Talairach J, Buser P, et al (1971) [Postanoxic-action and intention myoclonus. Stereotaxic study and destruction of the lateral ventral nucleus of the thalamus]. Rev Neurol 124:5–20 [Google Scholar]
  • Tai KK, Bhidayasiri R, Truong DD (2007) Post-hypoxic animal model of myoclonus. Parkinsonism Relat Disord 13:377–81 [CrossRef] [PubMed] [Google Scholar]
  • Frucht SJ, Trost M, Ma Y, Eidelberg D (2004) The metabolic topography of posthypoxic myoclonus. Neurology 62:1879–81 [CrossRef] [PubMed] [Google Scholar]
  • Matsumoto RR, Truong DD, Nguyen KD, et al (2000) Involvement of GABA(A) receptors in myoclonus. Mov Disord 15(Suppl 1):47–52 [CrossRef] [PubMed] [Google Scholar]
  • Welsh JP, Placantonakis DG, Warsetsky SI, et al (2002) The serotonin hypothesis of myoclonus from the perspective of neuronal rhythmicity. Adv Neurol 89:307–29 [PubMed] [Google Scholar]
  • Wijdicks EF, Parisi JE, Sharbrough FW (1994) Prognostic value of myoclonus status in comatose survivors of cardiac arrest. Ann Neurol 35:239–43 [CrossRef] [PubMed] [Google Scholar]
  • Levy DE, Caronna JJ, Singer BH, et al (1985) Predicting outcome from hypoxic-ischemic coma. JAMA 253:1420–6 [CrossRef] [PubMed] [Google Scholar]
  • Bouwes A, van Poppelen D, Koelman JH, et al (2012) Acute posthypoxic myoclonus after cardiopulmonary resuscitation. BMC Neurol 12:63 [CrossRef] [PubMed] [Google Scholar]
  • Nielsen N, Wetterslev J, Cronberg T, et al (2013) Targeted temperature management at 33°C versus 36°C after cardiac arrest. NEJM 369:2197–206 [Google Scholar]
  • Seder DB, Sunde K, Rubertsson S, et al (2015) Neurologic outcomes and postresuscitation care of patients with myoclonus following cardiac arrest. Crit Care Med 43:965–72 [CrossRef] [PubMed] [Google Scholar]
  • Young GB, Gilbert JJ, Zochodne DW (1990) The significance of myoclonic status epilepticus in postanoxic coma. Neurology 40:1843–8 [CrossRef] [PubMed] [Google Scholar]
  • Wijdicks EF, Young GB (1994) Myoclonus status in comatose patients after cardiac arrest. Lancet 343:1642–3 [CrossRef] [Google Scholar]
  • Datta S, Hart GK, Opdam H, et al (2009) Post-hypoxic myoclonic status: the prognosis is not always hopeless. Crit Care Resusc 11:39–41 [PubMed] [Google Scholar]
  • Greer DM (2013) Unexpected good recovery in a comatose post-cardiac arrest patient with poor prognostic features. Resuscitation 84:e81–2 [CrossRef] [PubMed] [Google Scholar]
  • Bisschops LL, van Alfen N, Bons S, et al (2011) Predictors of poor neurologic outcome in patients after cardiac arrest treated with hypothermia: a retrospective study. Resuscitation 82:696–701 [CrossRef] [PubMed] [Google Scholar]
  • Rossetti AO, Oddo M, Logroscino G, Kaplan PW (2010) Prognostication after cardiac arrest and hypothermia: a prospective study. Ann Neurol 67:301–7 [PubMed] [Google Scholar]
  • Oddo M, Rossetti AO (2014) Early multimodal outcome prediction after cardiac arrest in patients treated with hypothermia. Crit Care Med 42:1340–7 [CrossRef] [PubMed] [Google Scholar]
  • Venkatesan A, Frucht S (2006) Movement disorders after resuscitation from cardiac arrest. Neurol Clin 24:123–32 [CrossRef] [PubMed] [Google Scholar]
  • Werhahn KJ, Brown P, Thompson PD, Marsden CD (1997) The clinical features and prognosis of chronic posthypoxic myoclonus. Mov Disord 12:216–20 [CrossRef] [PubMed] [Google Scholar]
  • Mock CM, Schwetschenau KH (2012) Levocarnitine for valproic-acid-induced hyperammonemic encephalopathy. Am J Health Syst Pharm 69:35–9 [CrossRef] [PubMed] [Google Scholar]
  • Frucht S, Fahn S (2000) The clinical spectrum of posthypoxic myoclonus. Mov Disord 15(Suppl 1):2–7 [CrossRef] [PubMed] [Google Scholar]
  • Krauss GL, Bergin A, Kramer RE, et al (2001) Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam. Neurology 56:411–2 [CrossRef] [PubMed] [Google Scholar]
  • Tai KK, Truong DD (2007) Brivaracetam is superior to levetiracetam in a rat model of post-hypoxic myoclonus. J Neural Transm 114:1547–51 [CrossRef] [PubMed] [Google Scholar]
  • Kothare SV, Valencia I, Khurana DS, et al (2004) Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy. Epileptic Disord 6:267–70 [PubMed] [Google Scholar]
  • Crespel A, Gelisse P, Reed RC, et al (2013) Management of juvenile myoclonic epilepsy. Epilepsy Behav 28(Suppl 1):S81–6 [CrossRef] [PubMed] [Google Scholar]
  • Genton P, Nguyen VH, Mesdjian E (1998) Carbamazepine intoxication with negative myoclonus after the addition of clobazam. Epilepsia 39:1115–8 [CrossRef] [PubMed] [Google Scholar]
  • Caviness JN (2014) Treatment of myoclonus. Neurother 11:188–200 [CrossRef] [Google Scholar]
  • Wallace SJ (1998) Myoclonus and epilepsy in childhood: a review of treatment with valproate, ethosuximide, lamotrigine and zonisamide. Epilepsy Res 29:147–54 [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.